HCPCS Level II code G0070 denotes professional administration of intravenous chemotherapy or other highly complex intravenous drugs or biological infusions delivered in the patient's home, reported per infusion drug administration calendar day in 15-minute units. This code captures home-based infusion care where skilled clinical staff provide medication administration and monitoring—services that enable complex cancer and specialty drug therapies outside hospital or clinic settings. Nationally, home infusion services are increasingly important for patient convenience, capacity management in acute care settings, and care continuity for high-acuity therapies.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise overview of clinical context for home intravenous infusion, common billing and service characteristics tied to G0070, and concise benchmarking and policy considerations relevant to payers and provider organizations. The publication summarizes typical sites of service, coding implications for per-day and per-15-minute reporting, and what to expect in payer coverage scope at a national level. Data not available in the input for specific associated taxonomies, ICD-10 diagnoses, or related codes is noted where applicable.